Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder that leads to mucocutaneous telangiectasias, epistaxis, and gastrointestinal bleeding. Depending on the severity and manifestation of the disease, various therapeutic modalities have been used, from local bleeding control...

Descripción completa

Detalles Bibliográficos
Autores principales: Wee, Jee Wan, Jeon, Young Woo, Eun, Jun Young, Kim, Han Jo, Bae, Sang Byung, Lee, Kyu Taek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188786/
https://www.ncbi.nlm.nih.gov/pubmed/25325040
http://dx.doi.org/10.5045/br.2014.49.3.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188786/
https://www.ncbi.nlm.nih.gov/pubmed/25325040
http://dx.doi.org/10.5045/br.2014.49.3.192

Ejemplares similares